247 related articles for article (PubMed ID: 22322337)
1. The current challenges for vaccine development.
Oyston P; Robinson K
J Med Microbiol; 2012 Jul; 61(Pt 7):889-894. PubMed ID: 22322337
[TBL] [Abstract][Full Text] [Related]
2. Vaccine adjuvants: current challenges and future approaches.
Wilson-Welder JH; Torres MP; Kipper MJ; Mallapragada SK; Wannemuehler MJ; Narasimhan B
J Pharm Sci; 2009 Apr; 98(4):1278-316. PubMed ID: 18704954
[TBL] [Abstract][Full Text] [Related]
3. Beyond empiricism: informing vaccine development through innate immunity research.
Levitz SM; Golenbock DT
Cell; 2012 Mar; 148(6):1284-92. PubMed ID: 22424235
[TBL] [Abstract][Full Text] [Related]
4. New adjuvants for human vaccines.
Mbow ML; De Gregorio E; Valiante NM; Rappuoli R
Curr Opin Immunol; 2010 Jun; 22(3):411-6. PubMed ID: 20466528
[TBL] [Abstract][Full Text] [Related]
5. Mucosal Vaccine Development Based on Liposome Technology.
Bernasconi V; Norling K; Bally M; Höök F; Lycke NY
J Immunol Res; 2016; 2016():5482087. PubMed ID: 28127567
[TBL] [Abstract][Full Text] [Related]
6. Whither vaccines?
Rodrigues CMC; Pinto MV; Sadarangani M; Plotkin SA
J Infect; 2017 Jun; 74 Suppl 1():S2-S9. PubMed ID: 28646957
[TBL] [Abstract][Full Text] [Related]
7. Accelerating next-generation vaccine development for global disease prevention.
Koff WC; Burton DR; Johnson PR; Walker BD; King CR; Nabel GJ; Ahmed R; Bhan MK; Plotkin SA
Science; 2013 May; 340(6136):1232910. PubMed ID: 23723240
[TBL] [Abstract][Full Text] [Related]
8. Progress in vaccine development.
Moyle PM
Curr Protoc Microbiol; 2015 Feb; 36():18.1.1-18.1.26. PubMed ID: 25641099
[TBL] [Abstract][Full Text] [Related]
9. The path forward.
De Gregorio E
Vaccine; 2015 Jun; 33 Suppl 2():B60-3. PubMed ID: 26022572
[TBL] [Abstract][Full Text] [Related]
10. Letter from the editor.
Ellis R; Riedmann EM
Hum Vaccin Immunother; 2013 Apr; 9(4):721. PubMed ID: 24091588
[No Abstract] [Full Text] [Related]
11. [Subunit vaccines--antigens, carriers, conjugation methods and the role of adjuvants].
Jarząb A; Skowicki M; Witkowska D
Postepy Hig Med Dosw (Online); 2013 Nov; 67():1128-43. PubMed ID: 24379254
[TBL] [Abstract][Full Text] [Related]
12. Innate immunity and new adjuvants.
Mutwiri G; Gerdts V; Lopez M; Babiuk LA
Rev Sci Tech; 2007 Apr; 26(1):147-56. PubMed ID: 17633299
[TBL] [Abstract][Full Text] [Related]
13. Novel vaccines: bridging research, development and production.
Demirjian A; Levy O
Expert Rev Vaccines; 2008 Nov; 7(9):1321-4. PubMed ID: 18980535
[TBL] [Abstract][Full Text] [Related]
14. An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators.
Chauhan N; Tiwari S; Iype T; Jain U
Expert Rev Vaccines; 2017 May; 16(5):491-502. PubMed ID: 28285554
[TBL] [Abstract][Full Text] [Related]
15. Modern Vaccine Adjuvant/Formulation--Session 9: Adjuvants.
Dalençon F
Hum Vaccin Immunother; 2013 Sep; 9(9):2013-4. PubMed ID: 23938771
[TBL] [Abstract][Full Text] [Related]
16. Vaccines, our shared responsibility.
Pagliusi S; Jain R; Suri RK;
Vaccine; 2015 May; 33(19):2197-2202. PubMed ID: 25749248
[TBL] [Abstract][Full Text] [Related]
17. From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease.
Mortellaro A; Ricciardi-Castagnoli P
Immunol Cell Biol; 2011 Mar; 89(3):332-9. PubMed ID: 21301476
[TBL] [Abstract][Full Text] [Related]
18. Cancer vaccine adjuvants--recent clinical progress and future perspectives.
Banday AH; Jeelani S; Hruby VJ
Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):1-11. PubMed ID: 25318595
[TBL] [Abstract][Full Text] [Related]
19. Adjuvants: no longer a 'dirty little secret', but essential key players in vaccines of the future.
Arakawa T
Expert Rev Vaccines; 2011 Jan; 10(1):1-5. PubMed ID: 21162613
[No Abstract] [Full Text] [Related]
20. The impact of vaccines and vaccinations: Challenges and opportunities for modelers.
Curtiss R
Math Biosci Eng; 2011 Jan; 8(1):77-93. PubMed ID: 21361401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
